A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 197
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ARMS
Long Form : alveolar rhabdomyosarcoma
No. Year Title Co-occurring Abbreviation
2020 A modified human Myogenin promoter that is highly active in alveolar rhabdomyosarcoma. HSV-TK
2020 Alveolar Rhabdomyosarcoma Following Mandibular Distraction Osteogenesis. ---
2020 Assessing alveolar rhabdomyosarcoma cell lines as tumor models by comparison of mRNA expression profiles. ---
2020 Do children and adolescents with completely resected alveolar rhabdomyosarcoma require adjuvant radiation? A report from the Children's Oncology Group. COG, EFS, OS, RT
2020 Establishment and characterization of a novel alveolar rhabdomyosarcoma cell line, NCC-aRMS1-C1. ---
2020 Fenretinide induces a new form of dynamin-dependent cell death in pediatric sarcoma. 3-MA, FP-RMS, ROS
2020 Molecular mechanisms of Guadecitabine induced FGFR4 down regulation in alveolar rhabdomyosarcomas. ChIP-seq, DNMTi, FGFR4, RMS
2020 Primary pharyngeal alveolar rhabdomyosarcoma in an adolescent Japanese black heifer. ---
2020 Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case report. NKG2D
10  2019 "Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines". ERMS, Hpo, RMS, TAZ, VP
11  2019 Alveolar rhabdomyosarcoma with unusual cytogenetic findings: one more case and review of the literature. RMS
12  2019 An Adult Patient With Rare Primary Intracranial Alveolar Rhabdomyosarcoma. CNS
13  2019 Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma. ---
14  2019 Evaluation of entinostat alone and in combination with standard-of-care cytotoxic agents against rhabdomyosarcoma xenograft models. ERMS
15  2019 Exfoliation of Alveolar Rhabdomyosarcoma Cells in the Ascites of a 50-Year-Old Woman: Diagnostic Challenges and Literature Review. ---
16  2019 Preclinical rationale for entinostat in embryonal rhabdomyosarcoma. ENT, PDX, RMS, VCR
17  2019 Primary alveolar rhabdomyosarcoma of retrorectal-presacral space in an adult patient: A case report of an uncommon tumor with rare presentation. CT, MRI, RMS
18  2019 Primary CNS Alveolar Rhabdomyosarcoma: Importance of Epigenetic and Transcriptomic Assays for Accurate Diagnosis. ---
19  2019 [Clinicopathological features and prognosis of pediatric alveolar rhabdomyosarcoma]. ---
20  2019 [Intraspinal metastasis of alveolar rhabdomyosarcoma: A case report]. ---
21  2019 [Round-cell sarcomas]. DSRCTs
22  2018 12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells. EZH2, PKC, RMS, TPA
23  2018 Alveolar Rhabdomyosarcoma Decellularization. ECM
24  2018 Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells. CPT
25  2018 Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). EpSSG, FOXO1
26  2018 Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma. HDAC5, IL-24
27  2018 Loss of MST/Hippo Signaling in a Genetically Engineered Mouse Model of Fusion-Positive Rhabdomyosarcoma Accelerates Tumorigenesis. GEMM
28  2018 PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma. FN-RMS
29  2018 Sinonasal Tract Alveolar Rhabdomyosarcoma in Adults: A Clinicopathologic and Immunophenotypic Study of Fifty-Two Cases with Emphasis on Epithelial Immunoreactivity. SNT
30  2018 Sphingosine Induces Apoptosis and Down-regulation of MYCN in PAX3-FOXO1-positive Alveolar Rhabdomyosarcoma Cells Irrespective of TP53 Mutation. MYCN, PAX3, TP53
31  2018 The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis. P3F
32  2018 Uterine rhabdomyosarcoma in adults. ERMS, PRMS, RMS
33  2017 Detection of FOXO1 break-apart status by fluorescence in situ hybridization in atypical alveolar rhabdomyosarcoma. ERMS, FISH, FOXO1, RMS
34  2017 Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group. COG, EFS, ERMS, RMS
35  2017 MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells. ERMS, HGF
36  2017 NFkappaB signaling in alveolar rhabdomyosarcoma. ---
37  2017 Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group. CI, EFS, ERMS
38  2017 PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1. C-DIM
39  2017 Pleural Alveolar Rhabdomyosarcoma. ---
40  2017 Preclinical testing of the glycogen synthase kinase-3beta inhibitor tideglusib for rhabdomyosarcoma. ERMS, RMS
41  2016 Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects. ---
42  2016 Alveolar rhabdomyosarcoma: morphoproteomics and personalized tumor graft testing further define the biology of PAX3-FKHR(FOXO1) subtype and provide targeted therapeutic options. ---
43  2016 Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma. HSV, RMS
44  2016 Fusion transcriptome profiling provides insights into alveolar rhabdomyosarcoma. ---
45  2016 Genomic Characterization of a Metastatic Alveolar Rhabdomyosarcoma Case Using FISH Studies and CGH+SNP Microarray Revealing FOXO1-PAX7 Rearrangement with MYCN and MDM2 Amplification and RB1 Region Loss. RMS
46  2016 Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma. CHD4
47  2016 Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group. COG, ERMS, RMS
48  2016 Melatonin action in tumor skeletal muscle cells: an ultrastructural study. DMSO, EtOH, MEL
49  2016 P/CAF mediates PAX3-FOXO1-dependent oncogenesis in alveolar rhabdomyosarcoma. ---
50  2016 RGD liposome-protamine-siRNA (LPR) nanoparticles targeting PAX3-FOXO1 for alveolar rhabdomyosarcoma therapy. LPR, LPR, P3F
51  2016 Severe Tumor Lysis Syndrome and Acute Pulmonary Edema Requiring Extracorporeal Membrane Oxygenation Following Initiation of Chemotherapy for Metastatic Alveolar Rhabdomyosarcoma. ECMO, TLS
52  2016 The proprotein convertase furin is required to maintain viability of alveolar rhabdomyosarcoma cells. RMS
53  2016 The RhoE/ROCK/ARHGAP25 signaling pathway controls cell invasion by inhibition of Rac activity. ERMS, RMS
54  2015 Aggressive, solid variant of alveolar rhabdomyosarcoma with cutaneous involvement in a juvenile labrador retriever. ---
55  2015 Alveolar Rhabdomyosarcoma in a 69-Year-Old Woman Receiving Glucagon-Like Peptide-2 Therapy. GLP-2, TPN
56  2015 Alveolar rhabdomyosarcoma of nasopharynx and paranasal sinuses with metastasis to breast in a middle-aged woman: a case report and literature review. CR
57  2015 Cryptic insertion of 3'FOXO1 into inverted chromosome arm 2q in the presence of two normal chromosome 13s and 13 small interstitial duplications in a patient with alveolar rhabdomyosarcoma. ---
58  2015 DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma. ERMS, RMS
59  2015 Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options. ---
60  2015 Modeling of the human alveolar rhabdomyosarcoma Pax3-Foxo1 chromosome translocation in mouse myoblasts using CRISPR-Cas9 nuclease. ---
61  2015 Molecular Cytogenetics Detect an Unbalanced t(2;13)(q36;q14) and PAX3-FOXO1 Fusion in Rhabdomyosarcoma With Mixed Embryonal/Alveolar Features. ERMS, FISH, RMS, RT-PCR
62  2015 PLK1 phosphorylates PAX3-FOXO1, the inhibition of which triggers regression of alveolar Rhabdomyosarcoma. ---
63  2015 The comparative utility of fluorescence in situ hybridization and reverse transcription-polymerase chain reaction in the diagnosis of alveolar rhabdomyosarcoma. FISH, PCR
64  2015 The Role of Immunohistochemistry in Rhabdomyosarcoma Diagnosis Using Tissue Microarray Technology and a Xenograft Model. ERMS, IHC, MRT, RMS
65  2014 A study of alveolar rhabdomyosarcoma copy number alterations by single nucleotide polymorphism analysis. DDIT3, GPC5
66  2014 Alveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression. PAX3-FOXO1, RASSF
67  2014 Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth. Cav-1, Cav-3, RMS
68  2014 Chromosomal and genetic imbalances in Chinese patients with rhabdomyosarcoma detected by high-resolution array comparative genomic hybridization. aCGH, CNVs, ERMS, FFPE, RMS
69  2014 Cranial metastatic alveolar rhabdomyosarcoma mimicking hematological malignancy in an adolescent boy. ---
70  2014 Cytologic diagnosis of metastatic alveolar rhabdomyosarcoma to the thyroid gland by fine-needle aspiration. TFNA
71  2014 Detection of common chromosomal translocations in small round blue cell pediatric tumors. DSRCT, SRBC, SS
72  2014 Glycogen synthase kinase 3beta represses MYOGENIN function in alveolar rhabdomyosarcoma. GSK3beta, MCK
73  2014 Lineage of origin in rhabdomyosarcoma informs pharmacological response. ---
74  2014 Nasopharyngeal alveolar rhabdomyosarcoma expressing CD56: a mimicker of extranodal natural killer/T-cell lymphoma. NK
75  2014 PDGFRbeta reverses EphB4 signaling in alveolar rhabdomyosarcoma. EPHB4
76  2013 A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma. ---
77  2013 Cell-based small-molecule compound screen identifies fenretinide as potential therapeutic for translocation-positive rhabdomyosarcoma. ---
78  2013 Classification of rhabdomyosarcoma and its molecular basis. ERMS, RMS
79  2013 Cyclin-dependent kinase 4 phosphorylates and positively regulates PAX3-FOXO1 in human alveolar rhabdomyosarcoma cells. CDK4
80  2013 Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. ERMS
81  2013 Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee. BM, ERMS, RMS
82  2013 Histology and fusion status in rhabdomyosarcoma. ERMS, ICR, RMS
83  2013 IL-4 receptor blockade abrogates satellite cell: rhabdomyosarcoma fusion and prevents tumor establishment. IL-4R
84  2013 P-cadherin is a direct PAX3-FOXO1A target involved in alveolar rhabdomyosarcoma aggressiveness. ---
85  2013 PAX3-FOXO1 induces up-regulation of Noxa sensitizing alveolar rhabdomyosarcoma cells to apoptosis. ---
86  2013 Rb1 loss modifies but does not initiate alveolar rhabdomyosarcoma. ---
87  2013 Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma. DAPK1, GREM1, HEY1, MYOD1, PAX3-FOXO1
88  2013 Rhabdomyosarcoma in adrenal region of a child with hypertension and fever: a case report and literature review. RMS
89  2013 Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma. ---
90  2013 Targeting oxidative stress in embryonal rhabdomyosarcoma. ERMS
91  2013 Therapeutic cytodifferentiation in alveolar rhabdomyosarcoma without genetic change of the PAX3-FKHR chimeric fusion gene: a case study. ---
92  2013 Vincristine, irinotecan, and temozolomide for treatment of relapsed alveolar rhabdomyosarcoma. VITA
93  2012 18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models. ERMS, FDG, PPP, UPS
94  2012 AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell. ---
95  2012 Alveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesis. ---
96  2012 An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcoma. SFKs
97  2012 Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR-dependent motility in alveolar rhabdomyosarcoma cells. CPT1A
98  2012 Differential expression of Kv1.3 and Kv1.5 voltage-dependent K+ channels in human skeletal muscle sarcomas. ERMS
99  2012 PAX3-FOXO1 and FGFR4 in alveolar rhabdomyosarcoma. FGFR4
100  2012 PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation. ---